APA (7th ed.) Citation

EP, J., DR, P., JM, C., PA, S., T, R., & IF, P. (2016). Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines. The Journal of pharmacology and experimental therapeutics, 356(2), 354. https://doi.org/10.1124/jpet.115.230052

Chicago Style (17th ed.) Citation

EP, Jane, Premkumar DR, Cavaleri JM, Sutera PA, Rajasekar T, and Pollack IF. "Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines." The Journal of Pharmacology and Experimental Therapeutics 356, no. 2 (2016): 354. https://doi.org/10.1124/jpet.115.230052.

MLA (9th ed.) Citation

EP, Jane, et al. "Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines." The Journal of Pharmacology and Experimental Therapeutics, vol. 356, no. 2, 2016, p. 354, https://doi.org/10.1124/jpet.115.230052.